We are live on ! Find out more
Russell Investments Group

Russell Investments Group Portfolio holdings

AUM $114B
1-Year Est. Return 41.71%
This Fund
S&P 500
This Quarter Est. Return
+19.73%
1 Year Est. Return
+41.71%
3 Year Est. Return
+123.74%
5 Year Est. Return
+158.32%
10 Year Est. Return
AUM
$50.5B
AUM Growth
+$4.08B
Cap. Flow
-$3.41B
Cap. Flow %
-6.74%
Top 10 Hldgs %
14.7%
Holding
3,325
New
145
Increased
930
Reduced
1,660
Closed
298

Top Sells

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$147M
2
MSFT icon
Microsoft
MSFT
+$130M
3
DXC icon
DXC Technology
DXC
+$126M
4
TSM icon
TSMC
TSM
+$90.3M
5
AAPL icon
Apple
AAPL
+$74.9M

Sector Composition

Rank Sector Weight
1 Technology 19.87%
2 Financials 14.16%
3 Consumer Discretionary 12.78%
4 Healthcare 12.28%
5 Communication Services 8.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PRTK
2601
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$250K ﹤0.01%
+40,153
New +$236K
PR
2602
Permian Resources
PR
$18B
$248K ﹤0.01%
165,925
CHMG icon
2603
Chemung Financial Corp
CHMG
$398M
$246K ﹤0.01%
7,283
EMKR
2604
DELISTED
Emcore Corp
EMKR
$246K ﹤0.01%
4,496
+331
+8% +$13.2K
IVAC
2605
DELISTED
Intevac Inc
IVAC
$245K ﹤0.01%
34,258
-1,670
-5% -$10K
BRY
2606
DELISTED
Berry Corp
BRY
$244K ﹤0.01%
66,534
THFF icon
2607
First Financial Corp
THFF
$971M
$244K ﹤0.01%
6,339
-5,140
-45% -$188K
ADMA icon
2608
ADMA Biologics
ADMA
$2.22B
$241K ﹤0.01%
+123,968
New +$261K
EHTH icon
2609
eHealth
EHTH
$39.4M
$241K ﹤0.01%
3,417
-13,023
-79% -$990K
WEYS icon
2610
Weyco Group
WEYS
$434M
$241K ﹤0.01%
15,214
-26,883
-64% -$455K
CFFN icon
2611
Capitol Federal Financial
CFFN
$1.1B
$240K ﹤0.01%
19,254
-19,123
-50% -$228K
GORV
2612
DELISTED
Lazydays
GORV
$240K ﹤0.01%
+493
New +$221K
GDP
2613
DELISTED
Goodrich Petroleum Corporation Common Stock
GDP
$239K ﹤0.01%
23,765
CIM
2614
Chimera Investment
CIM
$995M
$238K ﹤0.01%
7,760
-6,539
-46% -$189K
STRS
2615
DELISTED
STRATUS PPTYS INC
STRS
$238K ﹤0.01%
9,345
TFSL icon
2616
TFS Financial
TFSL
$4.85B
$238K ﹤0.01%
13,523
-1,919
-12% -$31.9K
AYX
2617
DELISTED
Alteryx Inc
AYX
$238K ﹤0.01%
+1,955
New +$246K
APTX
2618
DELISTED
Aptinyx Inc. Common Stock
APTX
$238K ﹤0.01%
68,818
+30,999
+82% +$108K
GALT icon
2619
Galectin Therapeutics
GALT
$321M
$237K ﹤0.01%
106,075
UTI icon
2620
Universal Technical Institute
UTI
$1.45B
$237K ﹤0.01%
36,874
-2,190
-6% -$12.5K
FUNC icon
2621
First United
FUNC
$295M
$236K ﹤0.01%
15,255
CCRD
2622
DELISTED
CoreCard
CCRD
$235K ﹤0.01%
5,876
-3,600
-38% -$142K
IMAX icon
2623
IMAX
IMAX
$2.76B
$235K ﹤0.01%
13,092
UNTY icon
2624
Unity Bancorp
UNTY
$611M
$235K ﹤0.01%
13,427
-500
-4% -$7.9K
GH icon
2625
Guardant Health
GH
$22.3B
$234K ﹤0.01%
1,820
-296
-14% -$34.1K

Similar funds

Russell Investments Group's Q4 2020 Portfolio in Review

As of Q4 2020, Russell Investments Group held 3,325 positions worth $50.5B, up 8.8% from $46.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Russell Investments Group withdrew a net $3.41B in Q4 2020, closing 298 positions and reducing 1,660 holdings. Its most notable exit was Viatris, an estimated $53.2M position sold in full.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Russell Investments Group opened a new position in Unilever worth $23.7M.

  • Russell Investments Group's largest Q4 2020 buy was Unilever: 348,938 shares worth $23.7M.
  • Russell Investments Group added most to Bank of America in Q4 2020, an estimated $76M increase.
  • Russell Investments Group's biggest Q4 2020 reduction was Alibaba, cutting an estimated $147M.
  • Russell Investments Group fully exited Viatris in Q4 2020, selling an estimated $53.2M.
  • Russell Investments Group's ten largest holdings make up 15% of its $50.5B portfolio in Q4 2020.
  • Russell Investments Group opened 145 new positions and closed 298 in Q4 2020.
  • Russell Investments Group's portfolio value rose 8.8% quarter-over-quarter to $50.5B.

Based on Russell Investments Group's 13F filing for Q4 2020, filed 8 Feb 2021.